This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Leland Stanford Junior University. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Gregory M Enns: Innovator in Mitochondrial Dysfunction Treatment
Introduction
Gregory M Enns is a notable inventor based in Palo Alto, CA. He has made significant contributions to the field of mitochondrial dysfunction treatment. His innovative approaches have the potential to improve the quality of life for individuals affected by this condition.
Latest Patents
Enns holds a patent for "Methods and formulations to treat mitochondrial dysfunction." This patent outlines methods of treatment and pharmaceutical formulations designed to address both primary and secondary mitochondrial dysfunction. The techniques involve the use of an agonist of AMPK, which activates ATP-producing pathways while inhibiting ATP-consuming pathways. This dual action allows for the alleviation of symptoms associated with mitochondrial dysfunctions.
Career Highlights
Gregory M Enns is affiliated with Leland Stanford Junior University, where he continues to advance research in his field. His work is characterized by a commitment to developing effective treatments for complex health issues.
Collaborations
Enns collaborates with esteemed colleagues, including Tereza Moore and Tina M Cowan. Their combined expertise enhances the research and development of innovative solutions in mitochondrial health.
Conclusion
Gregory M Enns is a pioneering inventor whose work in mitochondrial dysfunction treatment exemplifies the intersection of innovation and healthcare. His contributions are poised to make a lasting impact on the field.